Market revenue in 2023 | USD 464.1 million |
Market revenue in 2030 | USD 670.2 million |
Growth rate | 5.4% (CAGR from 2023 to 2030) |
Largest segment | Point-of-care (poc) testing devices |
Fastest growing segment | Point-of-care (POC) Testing Devices |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Point-of-care (POC) Testing Devices, Laboratory-based Testing Devices |
Key market players worldwide | Bio-Rad Laboratories Inc, Abbott Laboratories, Roche, Siemens Healthineers AG ADR, Trinity Biotech PLC ADR, Menarini Group, Sekisui Chemical Co Ltd |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hba1c testing devices market will help companies and investors design strategic landscapes.
Point-of-care (poc) testing devices was the largest segment with a revenue share of 76.54% in 2023. Horizon Databook has segmented the Europe hba1c testing devices market based on point-of-care (poc) testing devices, laboratory-based testing devices covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe hba1c testing devices market, including forecasts for subscribers. This continent databook contains high-level insights into Europe hba1c testing devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account